Aniracetam

This classification denotes a neuroprotective agent with the molecular formula C12H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 5L16LKN964, chemically known as 2-pyrrolidinone, 1-(4-methoxybenzoyl)- but more generally known as aniracetam, which bears US NIH Compound Identifier 2196. European Medicines Agency schedules Aniracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05517MIG. The term ANIRACETAM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules aniracetam in its Anatomical Therapeutic Chemical (ATC) Classification. ANIRACETAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule aniracetam under HS 29337900 and SITC 51561. As of Q4 2014, ANIRACETAM remains US FDA's Preferred Term for this commodity. Aniracetam bears US NLM identifiers UMLS ID C0051917 and NCI Concept Code C65236. SMILES: COC1=CC=C(C=C1)C(=O)N2CCCC2=O.